Accuray, Inc. (ARAY)
1.105
+0.02
(+2.31%)
USD |
NASDAQ |
Dec 11, 16:00
1.09
-0.02
(-1.36%)
After-Hours: 20:00
Accuray Research and Development Expense (TTM): 47.10M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Becton, Dickinson & Co. | 1.264B |
| West Pharmaceutical Services, Inc. | 71.00M |
| Perspective Therapeutics, Inc. | 61.22M |
| Xtant Medical Holdings, Inc. | 2.165M |
| VolitionRX Ltd. | 9.144M |